{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:53:48Z","timestamp":1781610828600,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli studi \"Magna Graecia\" di Catanzaro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To describe the main glycemic outcomes and the Quality of Life (QOL) observed in a cohort of people with type 1 (T1D) or type 2 (T2D) insulin-treated diabetes under dialysis who started an Automated Insulin Delivery (AID) system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a longitudinal retrospective pilot real-world analysis of 14 individuals with T1D and T2D undergoing dialysis who began using an AID system to optimize glycemic control. All subjects used the MiniMed\u2122 780G system. Glucose metrics were collected at baseline, 3, 6, and 12 months after initiating the SmartGuard\u2122 feature. The WHOQoL-Bref questionnaire was administered at the last follow-up to evaluate the QOL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of the 14 people, 8 reached 1-year follow-up. Time in Range (TIR) increased from 63% at baseline to 69% at 12 months, Time Below Range &lt;\u200970\u00a0mg\/dL (TBR70) decreased from 0.3% to 0%, and Time Above Range &gt;\u2009250\u00a0mg\/dL (TAR250) decreased from 6.7% to 3.9%. Seven out of eight subjects who reached a 12-month follow-up achieved all three glycemic targets for this fragile population (TIR\u2009&gt;\u200950%, TBR70\u2009&lt;\u20091% and TAR250\u2009&lt;\u200910%). At the last follow-up, 58.3% of the users were satisfied or very satisfied with their health status, versus only 25% with the previous treatment, and 81.7% had a good or very good QOL, whereas only 8.3% had a good QOL, and no one had a very good QOL with the previous treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This pilot real-world study showed how the use of an AID system is safe and can help to improve the glycemic outcomes and the QOL of people with diabetes in dialysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00592-026-02690-9","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:30:57Z","timestamp":1776241857000},"page":"1083-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of automated insulin delivery (AID) systems in glucose control in patients with diabetes mellitus undergoing dialysis in Calabria: AID-DIAL-CAL"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2578-692X","authenticated-orcid":false,"given":"Elena","family":"Succurro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cersosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sarnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Brisinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Gattuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fabiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Mazzitello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Nicotera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Capria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Andreucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2690_CR1","unstructured":"IDF Atlas Report (2023) Diabetes and kidney disease. https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-reports\/diabetes-a"},{"key":"2690_CR2","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JN, Rhee CM, Rosas SE, Rossing P, Bakris G (2022) Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care 45:3075\u20133090. https:\/\/doi.org\/10.2337\/dci22-0027","journal-title":"Diabetes Care"},{"issue":"1 Suppl 1","key":"2690_CR3","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.2337\/dc25-S011","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) Chronic kidney disease and risk management: standards of care in diabetes-2025. Diabetes Care 48(1 Suppl 1):S239\u2013S251. https:\/\/doi.org\/10.2337\/dc25-S011","journal-title":"Diabetes Care"},{"key":"2690_CR4","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2337\/dc21-1579","volume":"45","author":"RJ Galindo","year":"2022","unstructured":"Galindo RJ, Ali MK, Funni SA, Dodge AB, Kurani SS, Shah ND, Umpierrez GE, McCoy RG (2022) Hypoglycemic and hyperglycemic crises among U.S. adults with diabetes and end- stage kidney disease: population-based study. Diabetes Care 45:2013\u20132017. https:\/\/doi.org\/10.2337\/dc21-1579","journal-title":"Diabetes Care"},{"key":"2690_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","volume":"41","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Beck RW, Scioscia MF, Umpierrez GE, Tuttle KR (2020) Glycemic monitoring and management in advanced chronic kidney disease. Endocr Rev 41:756\u2013774. https:\/\/doi.org\/10.1210\/endrev\/bnaa017","journal-title":"Endocr Rev"},{"key":"2690_CR6","doi-asserted-by":"publisher","unstructured":"Chu YW, Lin HM, Wang JJ, Weng SF, Lin CC, Chien CC Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: a national cohort study (2017). PLoS ONE 12(3):e0174601. https:\/\/doi.org\/10.1371\/journal.pone.0174601","DOI":"10.1371\/journal.pone.0174601"},{"key":"2690_CR7","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1007\/s00125-024-06165-w","volume":"67","author":"CK Boughton","year":"2024","unstructured":"Boughton CK, Hovorka R (2024) The role of automated insulin delivery technology in diabetes. Diabetologia 67:2034\u20132044. https:\/\/doi.org\/10.1007\/s00125-024-06165-w","journal-title":"Diabetologia"},{"key":"2690_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2023.0438","volume":"26","author":"C Mathieu","year":"2024","unstructured":"Mathieu C, Ahmed W, Gillard P, Cohen O, Vigersky R, de Portu S, Ozdemir Saltik AZ (2024) The health economics of automated insulin delivery systems and the potential use of time in range in diabetes modeling: a narrative review. Diabetes Technol Ther 26:66\u201375. https:\/\/doi.org\/10.1089\/dia.2023.0438","journal-title":"Diabetes Technol Ther"},{"key":"2690_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/dia.2023.0442","volume":"26","author":"EG Considine","year":"2024","unstructured":"Considine EG, Sherr JL (2024) Real-world evidence of automated insulin delivery system use. Diabetes Technol Ther 26:53\u201365. https:\/\/doi.org\/10.1089\/dia.2023.0442","journal-title":"Diabetes Technol Ther"},{"key":"2690_CR10","doi-asserted-by":"publisher","unstructured":"Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW (2019) iDCL Trial Research Group. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes N Engl J Med 381:1707\u20131717. https:\/\/doi.org\/10.1056\/NEJMoa1907863","DOI":"10.1056\/NEJMoa1907863"},{"key":"2690_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/dia.2020.0572","volume":"23","author":"E Isganaitis","year":"2021","unstructured":"Isganaitis E, Raghinaru D, Ambler-Osborn L, Pinsker JE, Buckingham BA, Wadwa RP, Ekhlaspour L, Kudva YC, Levy J, Forlenza CJ, Beck GP, Kollman RW, Lum C, Brown JW, Laffel SA, iDCL Trial Research Group (2021) Closed-loop insulin therapy improves glycemic control in adolescents and young adults: outcomes from the international diabetes closed-loop trial. Diabetes Technol Ther 23:342\u2013349. https:\/\/doi.org\/10.1089\/dia.2020.0572","journal-title":"Diabetes Technol Ther"},{"key":"2690_CR12","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.2337\/dc20-1447","volume":"43","author":"SA McAuley","year":"2020","unstructured":"McAuley SA, Lee MH, Paldus B, Vogrin S, de Bock MI, Abraham MB, Bach LA, Burt MG, Cohen ND, Colman PG, Davis EA, Hendrieckx C, Holmes-Walker DJ, Kaye J, Keech AC, Kumareswaran K, MacIsaac RJ, McCallum RW, Sims CM, Speight J, Stranks SN, Sundararajan V, Trawley S, Ward GM, Jenkins AJ, Jones TW, O\u2019Neal DN, Australian (2020) Six months of hybrid closed-loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: a randomized, controlled trial. Diabetes Care 43:3024\u20133033. https:\/\/doi.org\/10.2337\/dc20-1447. JDRF Closed-Loop Research Group","journal-title":"Diabetes Care"},{"key":"2690_CR13","doi-asserted-by":"publisher","unstructured":"Collyns OJ, Meier RA, Betts ZL, Chan DSH, Frampton C, Frewen CM, Hewapathirana NM, Jones SD, Roy A, Grosman B, Kurtz N, Shin J, Vigersky RA, Wheeler BJ, de Bock MI (2021) Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care 44:969\u2013975. https:\/\/doi.org\/10.2337\/dc20-2250","DOI":"10.2337\/dc20-2250"},{"key":"2690_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","volume":"392","author":"M Tauschmann","year":"2018","unstructured":"Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R (2018) APCam11 Consortium. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet 392:1321\u20131329. https:\/\/doi.org\/10.1016\/S0140-6736(18)31947-0","journal-title":"Lancet"},{"key":"2690_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.kint.2019.03.006","volume":"96","author":"L Bally","year":"2019","unstructured":"Bally L, Gubler P, Thabit H, Hartnell S, Ruan Y, Wilinska ME, Evans ML, Semmo M, Bruno Vogt B, Coll AP, Stettler C, Hovorka R (2019) Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis. Kidney Int 96:593\u2013596. https:\/\/doi.org\/10.1016\/j.kint.2019.03.006","journal-title":"Kidney Int"},{"key":"2690_CR16","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/s41591-021-01453-z","volume":"27","author":"CK Boughton","year":"2021","unstructured":"Boughton CK, Tripyla A, Hartnell S, Daly A, Herzig D, Wilinska ME, Czerlau C, Fry A, Bally L, Hovorka R (2021) Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial. Nat Med 27:1471\u20131476. https:\/\/doi.org\/10.1038\/s41591-021-01453-z","journal-title":"Nat Med"},{"key":"2690_CR17","doi-asserted-by":"publisher","unstructured":"Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Lia Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Lutz Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, N\u00f8rgaard K, O\u2019Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice (2023). Endocr Rev 4;44:254\u20132580. https:\/\/doi.org\/10.1210\/endrev\/bnac022","DOI":"10.1210\/endrev\/bnac022"},{"key":"2690_CR18","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Bioester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, N\u00f8rgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42:1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"key":"2690_CR19","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00125-024-06244-y","volume":"67","author":"RJ Galindo","year":"2024","unstructured":"Galindo RJ, Soliman D, Cher\u00f1avvsky D, Rhee CM (2024) Diabetes technology in people with diabetes and advanced chronic kidney disease. Diabetologia 67:2129\u20132142. https:\/\/doi.org\/10.1007\/s00125-024-06244-y","journal-title":"Diabetologia"},{"key":"2690_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/dia.2023.0433","volume":"26","author":"P Choudhary","year":"2024","unstructured":"Choudhary P, Arrieta A, van den Heuvel T, Casta\u00f1eda J, Smaniotto V, Cohen O (2024) CCelebrating the data from 100,000 Real-World users of the MiniMed\u2122 780G system in Europe, Middle East, and Africa collected over 3 Years: from data to Clinical Evidence. Diabetes Technol Ther 26:32\u201337. https:\/\/doi.org\/10.1089\/dia.2023.0433","journal-title":"Diabetes Technol Ther"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02690-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:16:28Z","timestamp":1781608588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02690-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2690"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02690-9","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}